Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:595-600
Published online before print January 8, 2004, doi: 10.1161/01.ATV.0000116219.09040.8c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/3/595    most recent
01.ATV.0000116219.09040.8cv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krötz, F.
Right arrow Articles by Pohl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krötz, F.
Right arrow Articles by Pohl, U.
Related Collections
Right arrow Secretion
Right arrow Aggregation
Right arrow Platelet function inhibitors
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:595.)
© 2004 American Heart Association, Inc.


Thrombosis

Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids

Florian Krötz; Tobias Riexinger; Martin A. Buerkle; Kasem Nithipatikom; Torsten Gloe; Hae-Young Sohn; William B. Campbell; Ulrich Pohl

From the Institute of Physiology (F.K., T.R., T.G., U.P.), Clinic of Anaesthesiology (M.A.B.), and Cardiology Division (H.-Y.S.), Medizinische Poliklinik–Innenstadt, Ludwig-Maximilians-University, Munich, Germany; and the Department of Pharmacology and Toxicology (K.N., W.B.C.), Medical College of Wisconsin, Milwaukee, Wisc.

Correspondence to Dr Florian Krötz, Institute of Physiology, Ludwig-Maximilians-Universität, Schillerstr. 44, 80336 München, Germany. E-mail fkroetz{at}lmu.de

Objective— Epoxyeicosatrienoic acids (EETs) are potent vasodilators produced by endothelial cells. In many vessels, they are an endothelium-derived hyperpolarizing factor (EDHF). However, it is unknown whether they act as an EDHF on platelets and whether this has functional consequences.

Methods and Results— Flow cytometric measurement of platelet membrane potential using the fluorescent dye DiBac4 showed a resting potential of -58±9 mV. Different EET regioisomers hyperpolarized platelets down to -69±2 mV, which was prevented by the non-specific potassium channel inhibitor charybdotoxin and by use of a blocker of calcium-activated potassium channels of large conductance (BKCa channels), iberiotoxin. EETs inhibited platelet adhesion to endothelial cells under static and flow conditions. Exposure to EETs inhibited platelet P-selectin expression in response to ADP. Stable overexpression of cytochrome P450 2C9 in EA.hy926 cells (EA.hy2C9 cells) resulted in release of EETs and a factor that hyperpolarized platelets and inhibited their adhesion to endothelial cells. These effects were again inhibited by charybdotoxin and iberiotoxin.

Conclusions— EETs hyperpolarize platelets and inactivate them by inhibiting adhesion molecule expression and platelet adhesion to cultured endothelial cells in a membrane potential-dependent manner. They act as an EDHF on platelets and might be important mediators of the anti-adhesive properties of vascular endothelium.


Key Words: epoxyeicosatrienoic acids • platelet adhesion • membrane potential • potassium channels • EDHF




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Krotz, N. Hellwig, M. A. Burkle, S. Lehrer, T. Riexinger, H. Mannell, H.-Y. Sohn, V. Klauss, and U. Pohl
A sulfaphenazole-sensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo
Cardiovasc Res, October 4, 2009; (2009) cvp301v2.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Zhang, T. Otsuka, N. Sugo, A. Ardeshiri, Y. K. Alhadid, J. J. Iliff, A. E. DeBarber, D. R. Koop, and N. J. Alkayed
Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia
Stroke, July 1, 2008; 39(7): 2073 - 2078.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. C Villar, A. J Hobbs, and A. Ahluwalia
Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor
J. Endocrinol., June 1, 2008; 197(3): 447 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Chlopicki, R. Olszanecki, E. Marcinkiewicz, M. Lomnicka, and R. Motterlini
Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase
Cardiovasc Res, July 15, 2006; 71(2): 393 - 401.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. T. Larsen, H. Miura, O. A. Hatoum, W. B. Campbell, B. D. Hammock, D. C. Zeldin, J. R. Falck, and D. D. Gutterman
Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H491 - H499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier
Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Wang, X. Wei, X. Xiao, R. Hui, J. W. Card, M. A. Carey, D. W. Wang, and D. C. Zeldin
Arachidonic Acid Epoxygenase Metabolites Stimulate Endothelial Cell Growth and Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 522 - 532.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Buerkle, S. Lehrer, H.-Y. Sohn, P. Conzen, U. Pohl, and F. Krotz
Selective Inhibition of Cyclooxygenase-2 Enhances Platelet Adhesion in Hamster Arterioles In Vivo
Circulation, October 5, 2004; 110(14): 2053 - 2059.
[Abstract] [Full Text] [PDF]